MX9706484A - Forma de dosis de agente activo de liberacion prolongada con bandas. - Google Patents
Forma de dosis de agente activo de liberacion prolongada con bandas.Info
- Publication number
- MX9706484A MX9706484A MX9706484A MX9706484A MX9706484A MX 9706484 A MX9706484 A MX 9706484A MX 9706484 A MX9706484 A MX 9706484A MX 9706484 A MX9706484 A MX 9706484A MX 9706484 A MX9706484 A MX 9706484A
- Authority
- MX
- Mexico
- Prior art keywords
- active agent
- dosage form
- agent dosage
- banded
- prolonged release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invencion va dirigida a una forma de dosis de agente activo que es util para la liberacion prolongada de una formulacion de agente activo a un medio ambiente fluido de uso, la forma de dosis de agente activo es una matriz que tiene sobre su superficie dos o más bandas insolubles; la invencion va dirigida también al método para hacer la forma de dosis de agente activo.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08394074 | 1995-02-24 | ||
US08/394,074 US5534263A (en) | 1995-02-24 | 1995-02-24 | Active agent dosage form comprising a matrix and at least two insoluble bands |
PCT/US1996/001848 WO1996025922A2 (en) | 1995-02-24 | 1996-02-09 | Banded prolonged release active agent dosage form |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9706484A true MX9706484A (es) | 1997-11-29 |
MXPA97006484A MXPA97006484A (es) | 1998-07-03 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
FI973452A (fi) | 1997-08-22 |
NO973840L (no) | 1997-10-22 |
US5534263A (en) | 1996-07-09 |
KR100465268B1 (ko) | 2005-04-06 |
CN1175901A (zh) | 1998-03-11 |
EP0810856A2 (en) | 1997-12-10 |
US5667804A (en) | 1997-09-16 |
WO1996025922A3 (en) | 1996-10-03 |
FI973452A0 (fi) | 1997-08-22 |
NZ303809A (en) | 1999-04-29 |
ES2155931T3 (es) | 2001-06-01 |
NO319216B1 (no) | 2005-07-04 |
GR3035743T3 (en) | 2001-07-31 |
HK1005794A1 (en) | 1999-01-29 |
KR19980702469A (ko) | 1998-07-15 |
US6316028B1 (en) | 2001-11-13 |
US6020000A (en) | 2000-02-01 |
JPH11500728A (ja) | 1999-01-19 |
ATE200421T1 (de) | 2001-04-15 |
DK0810856T3 (da) | 2001-05-07 |
JP3955320B2 (ja) | 2007-08-08 |
DE69612481D1 (de) | 2001-05-17 |
CN1142771C (zh) | 2004-03-24 |
EP0810856B1 (en) | 2001-04-11 |
AU703681B2 (en) | 1999-04-01 |
DE69612481T2 (de) | 2001-07-26 |
NO973840D0 (no) | 1997-08-21 |
WO1996025922A2 (en) | 1996-08-29 |
AU5022696A (en) | 1996-09-11 |
PT810856E (pt) | 2001-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996025922A3 (en) | Banded prolonged release active agent dosage form | |
EP0744942A4 (en) | HYDROGEL FORMULATION WITH CONTROLLED RELEASE | |
GEP20012388B (en) | Metalloproteinase Inhibitors, Pharmaceutical Compositions on Their Base, Use and Methods for Obtaining and Intermediates | |
CA2328998A1 (en) | Method of fabricating a banded prolonged release active agent dosage form | |
FR2688422B1 (es) | ||
NZ308293A (en) | Antibacterial-wound healing compositions comprising a pyruvate, antioxidant and fatty acids | |
MX9602683A (es) | Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas. | |
BG102200A (en) | Transcorneal system for the release of a medicament | |
PL321898A1 (en) | Application of inorganic aerogles in pharmaceutics | |
BG101901A (en) | 2-methyl-thieno-benzodiazepine formulation for oral application | |
AU2003297260A1 (en) | Fast-disintegrating solid dosage forms being not friable and comprising pullulan | |
UA34466C2 (uk) | Засіб для несистемної боротьби з паразитуючими комахами | |
MY118151A (en) | Pharmaceutical formulations containing voriconazole. | |
UA90077C2 (uk) | Антидисритмічні агенти для лікування тазового болю, що призначаються вагінально | |
MY115433A (en) | Film coated tablet of paracetamol and domperidone. | |
MX9601994A (es) | Profarmacos de derivados de paclitaxel. | |
EP0856315A4 (en) | DRUG | |
MX9705806A (es) | Forma farmaceutica destinada a la cesion de colagenasa en heridas, y procedimiento para su elaboracion. | |
MY128312A (en) | Pesticidal formulation | |
NZ515685A (en) | Use of riluzole for the treatment of multiple sclerosis | |
HUT41002A (en) | Process for preparing anticonvulsives | |
CA2207098A1 (en) | Banded prolonged release active agent dosage form | |
AU3315200A (en) | 1,5-anhydro-d-fructose substituted with a hydrophobic group for use as anti-oxidant and/or emulsifier | |
UA32598C2 (uk) | Спосіб одержання лікарської форми карбамазепіну | |
NZ333443A (en) | Method of treating a plant disease comprising applying oxi-fulvic acid an acitve ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |